Newsroom

Newsroom

Development and validation of automated flow cytometry system for the diagnosis and prediction of molecular abnormalities in myelodysplastic syndrome

Literature
Read More

Higher mutation rate in patients with aplastic anemia using peripheral blood cfDNA as compared with bone marrow cells

Literature
Read More

Interclonal and intraclonal heterogeneity in patients with IDH1/2 mutation

Literature
Read More

Using next generation sequencing of peripheral blood cfDNA as a clinical test in screening for hematologic neoplasms

Literature
Read More

Aggressive B-cell lymphomas: frequency, immunophenotype, and genetics in a reference laboratory population

Literature
Read More

NeoGenomics Reports 142% Revenue Growth to $60.8 Million and a Record $9.6 Million in Cash Flow from Operations in the Third Quarter of 2016

Press Release
Read More

NeoGenomics Schedules its Q3 2016 Earnings Release for October 26, 2016

Press Release
Read More

NeoGenomics Reports 159% Revenue Growth to $63.1 Million and Strong Gains in Profitability in the Second Quarter of 2016

Press Release
Read More

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients